Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroki Arai.
Annals of Nuclear Medicine | 1993
Hitoya Ohta; Tadao Enomoto; Takema Sakoda; Akira Shibano; Hiroki Arai; Michiaki Yokoyama; Tomoo Komibuchi; Kohzo Shizuki; Nobutaka Kuchii
Scintigraphic images with67Ga citrate and99mTc(v)-dimercaptosuccinic acid and MR image of a 16-year-old male with maxillary sinus liposarcoma (predominantly myxoid type) are reported. The MR image clearly indicated the exact location, size and anatomical relationship of the tumor. Scintigraphic evaluation was useful in suggesting the malignant nature of the tumor and showed no distant metastasis. Both examinations were effective in treating this case.
Practica oto-rhino-laryngologica | 1991
Michiaki Yokoyama; Takema Sakoda; Hiroki Arai; Tadao Enomoto
Synchronous reconstruction of the defect of the face and hard palate afterr maxillectomy was performed with free myocutaneous flaps. A 58-year-old male and a 65-year-old male were treated for maxillary cancer (T4N0) with total maxillectomy and resection of facial skin (include the orbital contents in the latter case). The defects were reconstructed synchronously with two types of free myocutaneous flap: rectus abdominis (the former case), latissimus dorsi (the latter case). They were able to eat two weeks after surgery and did not suffer from speech disturbance. The greatest advantage of using free myocutaneous flaps for such reconstruction is the availability of enough muscle to fill the dead space and sufficient skin and the chief disadvantage is the risk of herniation after removal of the rectus abdominis.
Practica oto-rhino-laryngologica | 1989
Tadahito Saito; Takaaki Kawaguchi; Junichi Yoda; Hiroki Arai; Toshihide Tabata
Immunological surveillance has been elucidated and many cytokines, which participate in the immunological response between cancer and host, has been detected with recent progress of biotechnology. Furthermore, recent genetic engineering enables clinical application of these cytokines in cancer treatment. In this article, the role of immunotherapy in multimodal treatment for head and neck cancer is reviewed, and clinical evaluation and prospect of local administration of recombinant interleukin-2 (rIL-2) is discussed.
Nippon Jibiinkoka Gakkai Kaiho | 1989
Tadahito Saito; Hiromu Kakiuti; Kiyonori Kuki; Masaya Yokota; Takasi Jinnin; Takaaki Kimura; Keiji Fujiwara; Jyuniti Yoda; Masaru Kunimoto; Hiroki Arai; Tosihide Tabata
Practica oto-rhino-laryngologica | 1994
Hiroki Arai; Yoshihiro Dake; Tadao Enomoto; Michiaki Yokoyama; Akira Shibano; Takema Sakoida; Yoshiaki Fujiki
Practica oto-rhino-laryngologica | 1993
Takema Sakoda; Michio Hazama; Michiaki Yokoyama; Hiroki Arai; Tadao Enomoto
Practica oto-rhino-laryngologica | 1992
Michiaki Yokoyama; Tadao Enomoto; Hiroki Arai; Akira Shibano; Takema Sakoda
Japanese jornal of Head and Neck Cancer | 1990
Tadahito Saito; Toshihide Tabata; Hiromu Kakiuti; Masaya Yokota; Takashi Jinnin; Takaaki Kimura; Keiji Fujiwara; Jhunichi Yoda; Hiroki Arai
Practica oto-rhino-laryngologica | 1989
Kazuya Kinoshita; Takeo Kusumoto; Takaaki Kawaguchi; Takaaki Kimura; Keiji Fujihara; Hiroshi Katoh; Junichi Yoda; Shinji Tamura; Yasuhiro Hayashi; Sayoko Kuki; Masaya Yokota; Tadahito Saito; Takao Samukawa; Takashi Jinnin; Hiroki Arai; Masaru Kunimoto; Kiyonori Kuki; Yoshihiro Dake; Hiromu Kakiuchi; Toshihide Tabata; Osamu Nishimura; Tatuya Shimizu; Shinji Maebeya; Masanobu Juhri
Practica oto-rhino-laryngologica | 1989
Junichi Yoda; Tadahito Saito; Takaaki Kawaguchi; Hiroki Arai; Toshihide Tabata